Abstract
The antithrombotic effects of bovine activated protein C (APC) and protein S were investigated in a rabbit model of microarterial thrombosis. Because of the species specificity of the APC-protein S interaction, bovine APC expresses potent anticoagulant activity in rabbit plasma only when bovine protein S is also present. This provided a way to assess the contribution of bovine protein S to the antithrombotic effect of bovine APC. Rabbits were infused with boluses of activated protein C (0.1, 0.2, 0.4, or 0.8 mg/kg), protein S (0.5 mg/kg), or activated protein C (0.1 or 0.01 mg/kg) plus protein S (0.5 mg/kg). APC alone produced a dose-dependent antithrombotic effect, but only the group receiving the highest dose differed significantly from controls. While a low dose of activated protein C (0.1 mg/kg) alone had no antithrombotic effect, together with protein S (0.5 mg/kg) it produced a potent response. The presented results demonstrate the in vivo significance of protein S as a cofactor to activated protein C. The data show that a potent antithrombotic effect, without hemorrhagic side effects or significant systemic anticoagulation, may be achieved by low doses of activated protein C when combined with protein S.
Full text
PDFImages in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Araki H., Nishi K., Ishihara N., Okajima K. Inhibitory effects of activated protein C and heparin on thrombotic arterial occlusion in rat mesenteric arteries. Thromb Res. 1991 May 1;62(3):209–216. doi: 10.1016/0049-3848(91)90194-2. [DOI] [PubMed] [Google Scholar]
- Arnljots B., Bergqvist D., Dahlbäck B. Inhibition of microarterial thrombosis by activated protein C in a rabbit model. Thromb Haemost. 1994 Sep;72(3):415–420. [PubMed] [Google Scholar]
- Arnljots B., Bergqvist D. Inhibition of heparin-resistant microarterial thrombosis by recombinant hirudin: a specific thrombin inhibitor. Plast Reconstr Surg. 1995 Apr;95(5):894–900. [PubMed] [Google Scholar]
- Arnljots B., Dougan P., Salemark L., Bergqvist D. Effects of streptokinase and urokinase on microarterial thrombosis and haemostasis. An experimental study in rabbits. Scand J Plast Reconstr Surg Hand Surg. 1994 Mar;28(1):9–13. doi: 10.3109/02844319409015988. [DOI] [PubMed] [Google Scholar]
- Arnljots B., Dougan P., Wieslander J. B., Salemark L., Bergqvist D. Platelet accumulation and thrombus formation after microarterial injury. An experimental study in rabbits. Scand J Plast Reconstr Surg Hand Surg. 1994 Sep;28(3):167–175. doi: 10.3109/02844319409015977. [DOI] [PubMed] [Google Scholar]
- Arnljots B., Wieslander J. B., Dougan P., Salemark L. Prevention of microvascular thrombosis with low-dose tissue plasminogen activator. Plast Reconstr Surg. 1992 Aug;90(2):281–288. [PubMed] [Google Scholar]
- Bertina R. M., Koeleman B. P., Koster T., Rosendaal F. R., Dirven R. J., de Ronde H., van der Velden P. A., Reitsma P. H. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994 May 5;369(6475):64–67. doi: 10.1038/369064a0. [DOI] [PubMed] [Google Scholar]
- Bertina R. M., van Wijngaarden A., Reinalda-Poot J., Poort S. R., Bom V. J. Determination of plasma protein S--the protein cofactor of activated protein C. Thromb Haemost. 1985 Apr 22;53(2):268–272. [PubMed] [Google Scholar]
- Bregengård C., Nordfang O., Wildgoose P., Svendsen O., Hedner U., Diness V. The effect of two-domain tissue factor pathway inhibitor on endotoxin-induced disseminated intravascular coagulation in rabbits. Blood Coagul Fibrinolysis. 1993 Oct;4(5):699–706. [PubMed] [Google Scholar]
- Broekmans A. W., Veltkamp J. J., Bertina R. M. Congenital protein C deficiency and venous thromboembolism. A study of three Dutch families. N Engl J Med. 1983 Aug 11;309(6):340–344. doi: 10.1056/NEJM198308113090604. [DOI] [PubMed] [Google Scholar]
- Comp P. C., Esmon C. T. Recurrent venous thromboembolism in patients with a partial deficiency of protein S. N Engl J Med. 1984 Dec 13;311(24):1525–1528. doi: 10.1056/NEJM198412133112401. [DOI] [PubMed] [Google Scholar]
- Dahlbäck B., Carlsson M., Svensson P. J. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci U S A. 1993 Feb 1;90(3):1004–1008. doi: 10.1073/pnas.90.3.1004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dahlbäck B., Hildebrand B. Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V. Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1396–1400. doi: 10.1073/pnas.91.4.1396. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dahlbäck B., Hildebrand B., Malm J. Characterization of functionally important domains in human vitamin K-dependent protein S using monoclonal antibodies. J Biol Chem. 1990 May 15;265(14):8127–8135. [PubMed] [Google Scholar]
- Dahlbäck B. Inhibition of protein Ca cofactor function of human and bovine protein S by C4b-binding protein. J Biol Chem. 1986 Sep 15;261(26):12022–12027. [PubMed] [Google Scholar]
- Dahlbäck B. Protein S and C4b-binding protein: components involved in the regulation of the protein C anticoagulant system. Thromb Haemost. 1991 Jul 12;66(1):49–61. [PubMed] [Google Scholar]
- Emekli N. B., Ulutin O. N. The protective effect of autoprothrombin II - anticoagulant on experimental DIC in animals. Haematologica. 1980 Oct;65(5):644–651. [PubMed] [Google Scholar]
- Faioni E. M., Franchi F., Asti D., Sacchi E., Bernardi F., Mannucci P. M. Resistance to activated protein C in nine thrombophilic families: interference in a protein S functional assay. Thromb Haemost. 1993 Dec 20;70(6):1067–1071. [PubMed] [Google Scholar]
- Greengard J. S., Sun X., Xu X., Fernandez J. A., Griffin J. H., Evatt B. Activated protein C resistance caused by Arg506Gln mutation in factor Va. Lancet. 1994 May 28;343(8909):1361–1362. doi: 10.1016/s0140-6736(94)92497-x. [DOI] [PubMed] [Google Scholar]
- Griffin J. H., Evatt B., Wideman C., Fernández J. A. Anticoagulant protein C pathway defective in majority of thrombophilic patients. Blood. 1993 Oct 1;82(7):1989–1993. [PubMed] [Google Scholar]
- Gruber A., Griffin J. H., Harker L. A., Hanson S. R. Inhibition of platelet-dependent thrombus formation by human activated protein C in a primate model. Blood. 1989 Feb 15;73(3):639–642. [PubMed] [Google Scholar]
- Gruber A., Hanson S. R., Kelly A. B., Yan B. S., Bang N., Griffin J. H., Harker L. A. Inhibition of thrombus formation by activated recombinant protein C in a primate model of arterial thrombosis. Circulation. 1990 Aug;82(2):578–585. doi: 10.1161/01.cir.82.2.578. [DOI] [PubMed] [Google Scholar]
- Hanson S. R., Griffin J. H., Harker L. A., Kelly A. B., Esmon C. T., Gruber A. Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates. J Clin Invest. 1993 Oct;92(4):2003–2012. doi: 10.1172/JCI116795. [DOI] [PMC free article] [PubMed] [Google Scholar]
- He X., Dahlbäck B. Molecular cloning, expression and functional characterization of rabbit anticoagulant vitamin-K-dependent protein S. Eur J Biochem. 1993 Nov 1;217(3):857–865. doi: 10.1111/j.1432-1033.1993.tb18314.x. [DOI] [PubMed] [Google Scholar]
- He X., Dahlbäck B. Rabbit plasma, unlike its human counterpart, contains no complex between protein S and C4b-binding protein. Thromb Haemost. 1994 Apr;71(4):446–451. [PubMed] [Google Scholar]
- Heeb M. J., Mesters R. M., Tans G., Rosing J., Griffin J. H. Binding of protein S to factor Va associated with inhibition of prothrombinase that is independent of activated protein C. J Biol Chem. 1993 Feb 5;268(4):2872–2877. [PubMed] [Google Scholar]
- Hillarp A., Dahlbäck B. Novel subunit in C4b-binding protein required for protein S binding. J Biol Chem. 1988 Sep 5;263(25):12759–12764. [PubMed] [Google Scholar]
- Koster T., Rosendaal F. R., de Ronde H., Briët E., Vandenbroucke J. P., Bertina R. M. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet. 1993 Dec 18;342(8886-8887):1503–1506. doi: 10.1016/s0140-6736(05)80081-9. [DOI] [PubMed] [Google Scholar]
- Marlar R. A., Neumann A. Neonatal purpura fulminans due to homozygous protein C or protein S deficiencies. Semin Thromb Hemost. 1990 Oct;16(4):299–309. doi: 10.1055/s-2007-1002683. [DOI] [PubMed] [Google Scholar]
- Regan L. M., Lamphear B. J., Huggins C. F., Walker F. J., Fay P. J. Factor IXa protects factor VIIIa from activated protein C. Factor IXa inhibits activated protein C-catalyzed cleavage of factor VIIIa at Arg562. J Biol Chem. 1994 Apr 1;269(13):9445–9452. [PubMed] [Google Scholar]
- Shen L., Dahlbäck B. Factor V and protein S as synergistic cofactors to activated protein C in degradation of factor VIIIa. J Biol Chem. 1994 Jul 22;269(29):18735–18738. [PubMed] [Google Scholar]
- Smirnov M. D., Pyzh M. V., Borovikov D. V., Atorozhilova A. N., Dobrovolsky A. B., Golubych V. L., Gratsiansky N. A. Low doses of activated protein C delay arterial thrombosis in rats. Thromb Res. 1990 Feb 15;57(4):645–650. doi: 10.1016/0049-3848(90)90082-n. [DOI] [PubMed] [Google Scholar]
- Solymoss S., Tucker M. M., Tracy P. B. Kinetics of inactivation of membrane-bound factor Va by activated protein C. Protein S modulates factor Xa protection. J Biol Chem. 1988 Oct 15;263(29):14884–14890. [PubMed] [Google Scholar]
- Stenflo J. A new vitamin K-dependent protein. Purification from bovine plasma and preliminary characterization. J Biol Chem. 1976 Jan 25;251(2):355–363. [PubMed] [Google Scholar]
- Stenflo J., Jönsson M. Protein S, a new vitamin K-dependent protein from bovine plasma. FEBS Lett. 1979 May 15;101(2):377–381. doi: 10.1016/0014-5793(79)81048-0. [DOI] [PubMed] [Google Scholar]
- Svensson P. J., Dahlbäck B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med. 1994 Feb 24;330(8):517–522. doi: 10.1056/NEJM199402243300801. [DOI] [PubMed] [Google Scholar]
- Tans G., Rosing J., Thomassen M. C., Heeb M. J., Zwaal R. F., Griffin J. H. Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles. Blood. 1991 Jun 15;77(12):2641–2648. [PubMed] [Google Scholar]
- Taylor F. B., Jr, Chang A., Esmon C. T., D'Angelo A., Vigano-D'Angelo S., Blick K. E. Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. J Clin Invest. 1987 Mar;79(3):918–925. doi: 10.1172/JCI112902. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Taylor F., Chang A., Ferrell G., Mather T., Catlett R., Blick K., Esmon C. T. C4b-binding protein exacerbates the host response to Escherichia coli. Blood. 1991 Jul 15;78(2):357–363. [PubMed] [Google Scholar]
- Voorberg J., Roelse J., Koopman R., Büller H., Berends F., ten Cate J. W., Mertens K., van Mourik J. A. Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V. Lancet. 1994 Jun 18;343(8912):1535–1536. doi: 10.1016/s0140-6736(94)92939-4. [DOI] [PubMed] [Google Scholar]
- Walker F. J. Protein S and the regulation of activated protein C. Semin Thromb Hemost. 1984 Apr;10(2):131–138. doi: 10.1055/s-2007-1004415. [DOI] [PubMed] [Google Scholar]
- Walker F. J. Regulation of activated protein C by protein S. The role of phospholipid in factor Va inactivation. J Biol Chem. 1981 Nov 10;256(21):11128–11131. [PubMed] [Google Scholar]
- Warr T. A., Rao L. V., Rapaport S. I. Disseminated intravascular coagulation in rabbits induced by administration of endotoxin or tissue factor: effect of anti-tissue factor antibodies and measurement of plasma extrinsic pathway inhibitor activity. Blood. 1990 Apr 1;75(7):1481–1489. [PubMed] [Google Scholar]
- Wieslander J. B., Dougan P., Stjernquist U., Mecklenburg C. V. Effect of dextran 70 and saline on thrombus formation following arteriotomy and intimectomy in small arteries. Microsurgery. 1986;7(4):168–177. doi: 10.1002/micr.1920070409. [DOI] [PubMed] [Google Scholar]
- Wieslander J. B., Dougan P. Washout of vessels with heparin does not improve patency following severe microarterial trauma: an experimental study. Ann Plast Surg. 1990 Mar;24(3):216–222. doi: 10.1097/00000637-199003000-00005. [DOI] [PubMed] [Google Scholar]
- Zöller B., Dahlbäck B. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis. Lancet. 1994 Jun 18;343(8912):1536–1538. doi: 10.1016/s0140-6736(94)92940-8. [DOI] [PubMed] [Google Scholar]